Deuterium Capital Management, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1860487
Clearwater, FL
Position in NTLA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,692,000
New position
Shares Held
100,000
first reported quarter
Ownership
0.071%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#91
of 327 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deuterium Capital Management, LLC holds $3,055,500 across 2 Biotechnology names. NTLA ranks #1 (55.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
This page
|
100,000 | $1,692,000 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
25,000 | $1,363,500 |
All Filings in NTLA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,692,000 | 100,000 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||